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the timetable of the expression of neurotransmitters and 
neuromodulators and their receptors. Disruption of the nor-
mal timing or intensity of neurotransmitter signaling can 
lead to permanent changes in proliferation, differentiation 
and growth of their target cells during the critical phases 
of brain development, providing potentially the underlying 
mechanism for neurobehavioral abnormalities (Herlenius 
and Lagercrantz, 2004). Functional maldevelopment of the 
brain can manifest as neurological, behavioral, emotional 
and/or cognitive dysfunctions, which in many cases occur 
in later development, during childhood, adolescence, adult-
hood or even in senescence. Attention-deficit hyperactivity 
disorder (ADHD), mental deficiency, schizophrenia, autism, 
affective disorders and anxiety were found to be associated 
with prenatal and early postnatal insults (Casper, 2004; 
Cannon and Clark, 2005; Langley et al., 2005; Kinney et al., 
2008). 
Developmental neurotoxicology deals with the study of 
adverse effects of chemical substances and physical agents 
on the developing nervous system. It is important to know 
the individual stages and factors that are critical in the 
morphogenetic and functional development of the nervous 
system, especially the brain, such as neuronal differentia-
tion, migration, cell-cell interactions, neuritic development, 
Evaluation of developmental neurotoxicity: 
some important issues focused on 
neurobehavioral development
Michal DuboVický 1, Pavel koVačoVský 2 , Eduard ujházy 1, jana NaVaroVá 1, ingrid bruckNEroVá 3, Mojmír Mach 1
1 Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic
2 Department of Psychology, Philosophical Faculty, Comenius University, Bratislava, Slovak Republic
3 1st Pediatric Hospital, School of Medicine, Comenius University, Bratislava, Slovak Republic
ITX013408A02  •  Received: 21 November 2008  •  Revised: 10 December 2008  •  Accepted: 15 December 2008  •  Electronic Publication: November 2010
ABSTRACT
Exposure of the developing organism to industrial chemicals and physical factors represents a serious risk factor for the development 
of neurobehavioral disorders, such as attention-deficit hyperactivity disorder, autism and mental retardation. Appropriate animal mod-
els are needed to test potentially harmful effects and mechanisms of developmental neurotoxicity of various chemical substances. 
However, there are significant human vs. rat differences in the brain developmental profile which should be taken into account in 
neurotoxicity studies. Subtle behavioral alterations are hard to detect by traditional developmental toxicity and teratogenicity studies, 
and in many cases they remain hidden. They can however be revealed by using special behavioral, endocrine and/or pharmacological 
challenges, such as repeated behavioral testing, exposure to single stressful stimulus or drugs. Further, current neurobehavioral test 
protocols recommend to test animals up to their adulthood. However some behavioral alterations, such as anxiety-like behavior or 
mental deficiency, may become manifest in later periods of development. Our experimental and scientific experiences are highly 
suggestive for a complex approach in testing potential developmental neurotoxicity. Strong emphasis should be given on repeated 
behavioral testing of animals up to senescence and on using proper pharmacological and/or stressful challenges. 
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Introduction
The central nervous system (CNS), especially the brain, 
is extremely sensitive during its whole ontogenesis to the 
action of various chemical substances and/or physical fac-
tors. The developing brain has unique characteristics and 
a different sensitivity to environmental insults compared 
to the adult already developed brain (O´Rahilly and Müller, 
2008).  Not  only  environmental  factors  but  also  drugs, 
stressful stimuli and other factors, such as hypoxia/isch-
emia, malnutrition, can interfere and/or interact with devel-
opmental processes of the brain. These in turn can finally 
result in subtle structural and/or functional alterations at 
the level of neurotransmitters and their receptors. Prenatal 
and perinatal insults, as e.g. developmental exposure to 
neuroactive drugs and environmental toxins can disturb 
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synaptogenesis, myelinogenesis, and development of neu-
rotransmitter systems (Slikker and Chang, 1998; Tilson, 
2000). One of the marked manifestations of CNS activity 
is a behavior which is defined as functional adaptation to 
the environment. Functional alterations of the CNS can 
occur as behavioral dysfunction in various manifestations. 
Werboff and Gottlieb (1963) were first to propose the notion 
of behavioral effects of developmental administration of 
chemical substances, as well as the term “behavioral teratol-
ogy”. The authors recognized the importance to use animal 
studies in evaluation of behaviorally disruptive effects of 
potential  developmental  insults  (chemicals,  drugs,  hor-
mones, different environmental impacts). It is actually very 
difficult to relate a behavioral deficit in children or in adults 
back to a drug taken by the mothers during pregnancy. 
Developmental neurotoxicity tests
Developmental neurotoxicologists have elaborated several 
approaches, methods, batteries of special behavioral tests 
to detect possible behavioral disruptive effects of various 
factors. There are two basic developmental neurotoxic-
ity (DNT) guidelines: Health Effects Test Guidelines 
OPPTS 870.6300 Developmental Neurotoxivity Study 
(EPA, 1998) and OECD Guideline for the Testing of 
Chemicals, Draft Proposal for a New Guideline 426, 
Developmental  Neurotoxicity  Study  (OECD,  1995). 
DNT studies are based on developmental exposure to a 
substance tested followed by assessment of growth and 
developmental landmarks, motor and sensory behaviors, 
cognitive  functions,  neurohistopathology,  and  mor-
phometrics. There are several behavioral test batteries 
in  developmental  neurotoxicology.  Test  batteries  are 
designed mostly for rats. The Cincinnati Test Battery 
is an important screening instrument developed over a 
period of several years by Vorhees, Butcher and Brunner 
at the University of Cincinnati (Vorhees et al., 1981; 1984). 
Adams,  Buelke-Sam,  Kimmel  and  their  colleagues  at 
the National Center for Toxicological research (NCTR) 
designed a test battery which is based on a large-scale 
Collaborative  Behavioral  Teratology  Study  (CBTS) 
performed by 6 different laboratories around US, including 
NCTR itself and Vorhees´s lab at Cincinnati (Adams et al., 
1985; Buelke-Sam et al., 1985). The CBTS test battery is 
summarized in Table 1. In Schwerzenbach, Switzerland, 
J. Elsner, along with his colleagues in Basel and Berlin, 
Germany, designed a study based on simplified manual 
tests conducted on young animals and complex automated 
test procedures performed on adults, known as European 
Collaborative Study (Elsner, 1986; Elsner et al., 1986). 
Fox (1965) performed the first complex investigation of 
reflex ontogeny and behavioral development in mice (Fox 
Battery). This study served as the basis for much of the 
subsequent works evaluating neurobehavioral effects of 
chemical substances in this species. Most recent behav-
ioral test batteries in mice were elaborated by Petruzzi 
et al. (1995) and Rayburn et al. (1997), and these include 
social interaction tests as well. 
Basic procedures of neurobehavioral testing
The main principle of the tests is that the substance tested 
is administered to females during gestation and lactation 
and their offspring are randomly selected from litters for 
neurobehavioral evaluation. At least three dose levels and 
a concurrent control should be used. The substance tested 
or vehicle should be administered daily to pregnant females 
from the time of implantation (day 6 of gestation) through-
out lactation up to postnatal day 21, so as to expose the off-
spring to the substance during their pre- and early postnatal 
development (OECD, 1995; EPA, 1998). Females are allowed 
to spontaneously deliver their pups. Before postnatal day 4, 
the size of each litter should be adjusted by eliminating extra 
pups by random selection (“culling”) to yield a uniform litter 
size for all litters, usually 8 pups per litter (4 males and 4 
females). Then neurobehavioral development of offspring is 
evaluated until adulthood, e.g. in the CBTS study, the last 
variable being tested on postnatal days 120–131. Specialized 
tests are used for assessment of neurobehavioral develop-
ment based on ethological analysis of animal behavior. The 
following categories of neurobehavioral development are 
investigated: somatic growth and maturation, neuromotor 
and reflex development, sensory functions, activity and 
emotionality levels, memory and learning. Individual tests 
are performed at distinctly established age or time intervals. 
In some test batteries pharmacological challenge and social 
behavior evaluation are involved. 
Table 1. 
The CBTS test battery for rats (Slikker & Chang, 1998)
Measure age at measurement (PD)
Physical growth 
Body weight  1, 7, 14, 21, 30, 60, 90, 110–120
Developmental landmarks
Upper and lower incisor eruption  7 – completion
Eye opening  12 – completion
Testes descent 21 – completion
Vaginal opening 30 – completion
Sensorimotor function
Negative geotaxis 7–10
Olfactory orientation  9–11
Auditory startle response (habituation) 18–19, 57–58
Activity and exploration
Figure 8 activity (1 hr test) 21, 60
Figure 8 activity (24 hr test) 100–108
Learning and memory
Visual discrimination operant task  75–89
Pharmacologic challenge
Figure 8 activity before and after 
D-amphetamine  120–131
PD – postnatal day208
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The somatic growth and maturation category does not 
represent typical behavioral variables, their observation is 
nevertheless important to obtain a complex view on devel-
opmental processes during early postnatal period. These 
data are significant for correlation with other developmen-
tal landmarks, and in turn for correct interpretation of the 
results obtained. The following developmental landmarks of 
maturation are usually observed: body weight, unfolding of 
external ear, incisor eruption, ear and eye opening, vaginal 
opening, testes descent. 
Neuromotor and reflex development tests serve for 
the evaluation of the level of motor development and its 
coordination and ability to maintain balance. The variables 
studied include the crossing of rods of different width, cliff 
avoidance, the ability so stay on a rotating rod, surface right-
ing, negative geotaxis, dynamic air righting, pivoting and 
forelimb grip strength.
Sensory function tests serve to determine the presence 
or absence of sensorimotor reactions of the animal, such as 
olfactory orientation or acoustic startle response. 
Activity and emotional reactivity level are mostly 
investigated in an open field test where intensity of motor 
activity (ambulation) and rearings is recorded by using 
various up-to-date techniques, such as video tracking or 
special infrared beams frames. Time spent in the central 
and/or peripheral parts of the open field arena and defeca-
tion rate are considered the measure of emotional reactivity 
to stressful stimuli in a new environment. Motor activity 
should be tested repeatedly to obtain more comprehensive 
information on animal exploratory behavior in novelty. 
Repeated testing in open field enables also the evaluation 
of gradual habituation of animals in a new environment. 
Consequently, within- and between-sessions habituation 
processes could be analyzed and compared. Despite the fact 
that coping behavior in novelty could be a sensitive indica-
tor of behavioral toxicity, complex habituation analyses 
are omitted in most of the neurotoxicity studies. In our 
previous studies, we thoroughly investigated habituation 
of exploratory behavior in neurobehavioral toxicities, and 
the results obtained are of relevance for evaluating behav-
ioral processes in the open field in a more complex way 
(Dubovický et al., 1997a,b; 1999a,b; 2004).
Learning and memory processes testing involves the 
above mentioned non-associative type of learning, habitu-
ation, further classical conditioning, such as active and 
passive avoidance learning, as well as complex learning 
processes, such as water maze, radial arm maze learning or 
visual discrimination operant task. 
Most important issues to be taken into 
account in neurobehavioral testing
It is important to note that the above mentioned tests are 
only recommended, they are not mandatory. These tests 
are not standardized; every neurobehavioral laboratory uses 
its own test battery, approaching more or less the recom-
mended guidelines of EPA and OECD, or generally used test 
batteries, such as CBTS. Selection of the tests depends on 
practical aspects, knowledge, and experience of the investi-
gators, and also on the characteristics of the experiment. In 
developmental neurotoxicity studies, it is important also to 
acknowledge the human versus rodent differences, namely 
differences in developmental processes in the brain, and in 
social, reproductive and maternal behavior. Due to these 
differences, chemical substances, drugs and other factors, 
may interact and/or interfere with developmental processes 
in the rat brain differently compared to human brain ontog-
eny. In the following part we mention the most important 
issues which should be taken into account in developmental 
neurotoxicity studies. 
Brain growth spurt 
Unlike precocial mammals, which give birth to relatively 
mature and mobile pups, such as guinea pig, hare and most 
ungulates, the rat, mouse and rabbit belong to the group 
of altricial species giving birth to immature, immobile, 
helpless pups. In contrast to precocial species, in altricial 
mammals  the  period  of  intensive  brain  growth  and 
maturation is shifted to the postnatal period, for rats with 
the peak on postnatal day 10 – 12. In humans, this brain 
growth "spurt" peaks in the perinatal period around birth 
(Dobbing and Sands, 1964; West 1993). The developmental 
time shift in rats is therefore advantageous for studies of 
the immature brain. By using neonatal rat pups we can also 
assess direct effects of various insults on the developing 
brain, on elimination of the maternal organism. In rats, 
organogenesis and histogenesis of the brain is completed 
prenatally and neurogenesis and migration is completed by 
postnatal day 10. However, synaptogenesis, gliogenesis and 
myelination, which begin prenatally, continue to develop 
and  they  are  not  completed  until  maturity  (Acuff  and 
Vorhees, 1998). Generally, this fact is not taken into account 
in developmental neurotoxicity studies. Extension of the 
dosing period at least to postnatal day 21, when the brain 
maturation is markedly progressed, postural, locomotor 
and other skills are completed and pups are able to survive 
without maternal care and can be weaned (Tilson, 2000), 
appears to be a strongly substantiated suggestion. 
Neuroendocrine system
The  neuroendocrine  system  enables  adaptation  of  the 
organism  to  an  ever  changing  environment.  It  can  be 
affected during the whole life by various factors. Excessive 
stressful stimuli can cause neuroendocrine and behavioral 
alterations in humans as well as in experimental animals 
(Dubovický  et  al.,  1999b;  Lanfumey  et  al.,  2008).  The 
developing neuroendocrine system is much more sensitive 
to prenatal and early postnatal insults. Neurotoxicants, 
intensive stressful stimuli and other factors can affect neu-
roendocrine and behavioral development in various ways. 
Alterations in the hypothalamic-pituitary-adrenal axis can 
be accompanied by long-term neurobehavioral changes. 
In  our  previous  studies,  we  found  gender-dependent 
changes in exploratory behavior and habituation in rats 
neonatally exposed to monosodium glutamate and stress-
ful stimuli (Dubovický et al., 1997b; 1999b). Sensitivity 
of the neuroendocrine system and its investigation from 209
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the developmental neurotoxicity point of view is mostly 
omitted. In many cases neuroendocrine changes could be 
hidden. Developmental changes can be revealed in reaction 
of the organism to special stimuli, such as pharmacological 
challenge or stressful stimuli. In our developmental study 
with phenytoin, we found an increased responsiveness of 
the neuroendocrine system in adult rats which were pre-
natally exposed to this drug. The mild stressful stimulus 
represented by one-min handling resulted in increased 
levels of adrenaline and noradrenaline (Makatsori et al., 
2005). It is important to note that there is evidence that 
neuroendocrine alterations induced in early development 
can be associated with depression, anxiety and other stress-
related diseases in later life (Maccari et al., 2003; Wilcoxon 
and Redei, 2007). Within neurodevelopmental studies it is 
relevant to investigate the reactivity of the neuroendocrine 
system and neurobehavioral variables related to anxiety 
and depression, such as anxiety- and depression-like behav-
ior of animals in elevated plus maze and test of behavioral 
despair, respectively. 
Single vs. repeated testing of animals
A test of motor activity is recommended at the time around 
weaning and repeatedly in adulthood. The tests could be a 
single one-day session or repeated more-days sessions. As to 
single or repeated testing, the guidelines are ambiguous. On 
using these two different approaches, different (sometimes 
opposite) results can be obtained. In our current experi-
mental practice we test animals repeatedly. Repeated testing 
in an open field test enables a more complex evaluation of 
the data obtained, such as habituation processes (Dubovický 
et al., 1997a, 1999a). In a series of experiments in which we 
investigated the effect of neonatal anoxia on motor activity 
in the open field at the time around weaning (single anoxia 
induced on postnatal days 2, 3, 4 or 5 in duration of 10, 15, 20 
or 25 min), we found a decrease in motor activity compared 
to controls in all time intervals. In the study of the effect 
of perinatal asphyxia on motor activity, we tested weaned 
rats repeatedly. We found a decrease of the activity on day 1 
of testing compared to controls. During the following test-
ing days, however, the activity had a tendency to increase 
(Dubovický et al., 2007). (Figures 1 and 2). These results 
highly suggest the necessity of repeated testing. A single 
test is inadequate, since some behavioral processes can be 
hidden and may become apparent at a later period of life. 
Termination of the neurobehavioral study
Termination of neurobehavioral testing is recommended at 
the period when animals are sexually mature, in rats it is 
about postnatal day 60–62. In the CBTS study, figure eight 
activity before and after D-amphetamine, is scheduled on 
postnatal days 120–130 (Slikker and Chang, 1998). Prenatal 
and neonatal insults, however, could manifest themselves 
in many cases in a later period in adulthood or even senes-
cence. Prenatally administered triethyltin was reported to 
cause spatial learning impairments at 2 years of age (Barone 
et al., 1995). Some consequences of perinatal asphyxia can 
appear in old rats, e.g. increased anxiety in senescent rats 
at the age of 18 months was found by Weitzdoerfer et al. 
(2002).  Moreover,  there  is  a  relationship  between  early 
exposure  and  increased  risk  for  neurodegenerative  and 
other  diseases  at  higher  age  (long-term  and/or  delayed 
effects). There are neurotoxicity studies confirming the role 
of developmental neurotoxicant exposure in the induction 
of neurodegenerative disorders, such as Parkinson´s disease 
(Barlow et al., 2007). Other factors, such as stressful stimuli, 
malnutrition or hypoxia can result in intrauterine growth 
restriction and in turn can lead to chronic diseases includ-
ing psychiatric diseases, e.g. schizophrenia. This concept 
is known as "fetal origin of adult diseases" (FOAD) (Sayer 
et al., 1997; Bezek et al., 2008). There is therefore a strong 
suggestion to shift neurobehavioral testing up to the period 
of senescence. Although this approach requires life-time 
testing, the results obtained could yield a better perspective 
to understand the problem of neurodegenerative and other 
diseases in maturity and senescence. 
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Figure 1. Effect of neonatal anoxia on day 2, 3, 4 or 5 post partum 
(PP), in duration of 10, 15, 20 or 25 min, on intensity of motor activity 
of rats in the open field test (single test). 
MS – marginal significance, *p < 0.05, **p < 0.01 – significant differ-
ences compared to controls.
Figure 2. Effect of perinatal asphyxia on day 20 of gestation (non-
sophisticated model), lasting 20 min, on intensity of motor activity 
of rats in the open field test (repeated 5 days of testing). 
*p < 0.05 – significant differences compared to controls (sum of 
motor activities on days 3, 4 and 5 of testing). 210
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Conclusions
In developmental neurotoxicity studies the different brain 
developmental profile of rats vs. humans should be taken 
into account. We would highly suggest to broaden neuro-
toxicity screening by investigation of the neuroendocrine 
system subjected to exposure to stressful stimuli in adult 
life. Evaluation of anxiety- and depression-like behavior 
appears also to be highly pertinent. In our experience, test-
ing motor activity repeatedly is of utmost importance in 
order to obtain relevant data on habituation of animals in a 
new environment. Neurobehavioral tests are not to be ter-
minated in adulthood. They should proceed to senescence 
so as to reveal potential long-term and/or delayed effects of 
chemical substances and other adverse factors. 
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